Maravai LifeSciences Files 8-K for Regulation FD Disclosure
Ticker: MRVI · Form: 8-K · Filed: Mar 20, 2025 · CIK: 1823239
| Field | Detail |
|---|---|
| Company | Maravai Lifesciences Holdings, Inc. (MRVI) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: MRVI
TL;DR
MRVI filed an 8-K for a Reg FD disclosure on 3/20/25 - could be material info.
AI Summary
Maravai LifeSciences Holdings, Inc. filed an 8-K on March 20, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report filed under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates Maravai LifeSciences is making a public disclosure under Regulation FD, which could contain material information for investors.
Risk Assessment
Risk Level: medium — The filing itself is routine, but the lack of specific detail about the Regulation FD disclosure introduces uncertainty about potential material information.
Key Players & Entities
- MARAVAI LIFESCIENCES HOLDINGS, INC. (company) — Registrant
- March 20, 2025 (date) — Date of Report
- Regulation FD (regulation) — Disclosure Type
- Securities Exchange Act of 1934 (law) — Governing Act
- Delaware (jurisdiction) — State of Incorporation
- San Diego, California (location) — Principal Executive Offices
FAQ
What is the specific nature of the Regulation FD Disclosure being made by Maravai LifeSciences?
The provided filing does not specify the content of the Regulation FD Disclosure, only that it is being made on March 20, 2025.
What is the purpose of filing a Form 8-K?
A Form 8-K is filed to announce major corporate events that shareholders should know about, such as Regulation FD disclosures.
When was Maravai LifeSciences Holdings, Inc. incorporated?
Maravai LifeSciences Holdings, Inc. was incorporated in Delaware.
What is the principal executive office address for Maravai LifeSciences?
The principal executive offices are located at 10770 Wateridge Circle Suite 200, San Diego, California 92121.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 20, 2025 regarding MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).